Archives: Press Releases

Partnerships Maximize Value of HiFi Data and Complete the Full End-to-End Workflow for PacBio Customers. MENLO PARK, Calif., Nov. 1, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality,…

Building on the MAS-Seq Concatenation Method, These Three New Kits can Significantly Increase Throughput in RNA Applications MENLO PARK, Calif., Oct. 31, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer…

MENLO PARK, Calif., Oct. 30, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023. Third quarter results Revenue of $55.7 million, a 72% increase…

Former CFO of Moderna, Amgen, and 3M Brings Decades of Relevant Experience to the PacBio Board MENLO PARK, Calif., Oct. 16, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of…

MENLO PARK, Calif., Oct. 12, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2023 financial results on…

New Program Expands Access to PacBio’s Highly Accurate Sequencing Systems by Providing Flexible Financing   MENLO PARK, Calif., Sept. 12, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality,…

Hamilton, Integra, Revvity, and Tecan Join PacBio Compatible to Offer Verified Automated Library Prep Workflows for Whole Genome Sequencing MENLO PARK, Calif., Sept. 7, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a…

MENLO PARK, Calif., Aug. 9, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming…

Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms  MENLO PARK, Calif. and STAMFORD, Conn., Aug. 7, 2023 /PRNewswire/ — PacBio (Nasdaq: PACB),…

MENLO PARK, Calif., Aug. 2, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2023. Second quarter results Revenue of $47.6 million, a 34%…

PacBio will Combine Apton’s Proprietary Sequencing Technology With its Highly Accurate Sequencing by Binding Chemistry to Develop a High-Throughput Sequencer Designed to Deliver Billions of Reads per Flow Cell MENLO…

The Onso Platform Delivers Extraordinary Accuracy Which Creates New Possibilities for Research and Translational Sequencing Applications MENLO PARK, Calif., Aug. 2, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of…

MENLO PARK, Calif., July 19, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2023 financial results on…

Bioscientia Acquires Multiple Revio Sequencing Systems to Revolutionize Rare Disease Research by Sequencing Thousands of Long-Read Human Genomes Annually MENLO PARK, Calif., June 28, 2023 /PRNewswire/ — PacBio, a leading developer…